EPCAM and neoplasm: Consistent with findings from EpCAM-AF680 NIRF imaging there were no statistically significant differences in tumor weights between groups (mean weight control group; 1.06 +/− 0.73 g, paclitaxel group; 0.91 +/− 1.01 g, trastuzumab group; 1.01 +/− 0.77 g) (F(2,21) = 0.07, p = 0.93, Figure 6E).